NasdaqGM - Nasdaq Real Time Price • USD
STAAR Surgical Company (STAA)
At close: 4:00 PM EDT
After hours: 4:03 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 9 |
| Avg. Estimate | 0.04 | 0.24 | 0.58 | 0.96 |
| Low Estimate | -0.05 | 0.19 | 0.3 | 0.66 |
| High Estimate | 0.11 | 0.34 | 0.74 | 1.18 |
| Year Ago EPS | 0.18 | 0.4 | 1.01 | 0.58 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 13 | 13 |
| Avg. Estimate | 74.91M | 95.33M | 338.69M | 394.41M |
| Low Estimate | 72M | 93M | 335.71M | 386.23M |
| High Estimate | 77.3M | 99.6M | 342.1M | 404.6M |
| Year Ago Sales | 66.96M | 92.31M | 322.42M | 338.69M |
| Sales Growth (year/est) | 11.90% | 3.30% | 5.00% | 16.50% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.03 | 0.19 | 0.18 | 0.17 |
| EPS Actual | 0.18 | 0.4 | 0.3 | 0.13 |
| Difference | 0.15 | 0.21 | 0.12 | -0.04 |
| Surprise % | 500.00% | 110.50% | 66.70% | -23.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.04 | 0.24 | 0.58 | 0.96 |
| 7 Days Ago | 0.04 | 0.24 | 0.58 | 0.96 |
| 30 Days Ago | 0.03 | 0.24 | 0.57 | 0.95 |
| 60 Days Ago | 0.16 | 0.33 | 0.91 | 1.29 |
| 90 Days Ago | 0.17 | 0.33 | 0.96 | 1.34 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | 4 | 2 | 3 | 4 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | STAA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -77.80% | -- | -- | 1.60% |
| Next Qtr. | -40.00% | -- | -- | 10.50% |
| Current Year | -42.60% | -- | -- | 5.20% |
| Next Year | 65.50% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 30.00% | -- | -- | 11.22% |
| Past 5 Years (per annum) | 37.13% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | Mizuho: Buy to Buy | 4/11/2024 |
| Maintains | Canaccord Genuity: Hold to Hold | 4/8/2024 |
| Reiterates | Needham: Hold | 4/4/2024 |
| Maintains | Stifel: Buy to Buy | 4/1/2024 |
| Upgrade | Stifel: Hold to Buy | 3/11/2024 |
| Maintains | Mizuho: Buy to Buy | 2/28/2024 |
Related Tickers
RGEN Repligen Corporation
157.14
+0.05%
COO The Cooper Companies, Inc.
90.42
+0.01%
OLYMY Olympus Corporation
13.72
-3.18%
RMD ResMed Inc.
178.91
+0.73%
ATRC AtriCure, Inc.
23.20
-0.81%
ICUI ICU Medical, Inc.
95.77
-1.17%
ISRG Intuitive Surgical, Inc.
366.34
-1.69%
WST West Pharmaceutical Services, Inc.
372.10
-1.39%
NVST Envista Holdings Corporation
19.97
+1.11%
TFX Teleflex Incorporated
206.62
-0.37%